Matches in Nanopublications for { ?s ?p "[There was also a significant difference in the expression of IGLV3-21 between chronic lymphocytic leukemia and leukemic chronic lymphoproliferative disorders (29.4 vs 4.8%, P = 0.018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_assertion description "[There was also a significant difference in the expression of IGLV3-21 between chronic lymphocytic leukemia and leukemic chronic lymphoproliferative disorders (29.4 vs 4.8%, P = 0.018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_provenance.
- NP389085.RA_2eaUMSjmcBHmiJkmcYcoFi9T4Px-cb6sXB9PY8cOOM130_assertion description "[There was also a significant difference in the expression of IGLV3-21 between chronic lymphocytic leukemia and leukemic chronic lymphoproliferative disorders (29.4 vs 4.8%, P = 0.018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389085.RA_2eaUMSjmcBHmiJkmcYcoFi9T4Px-cb6sXB9PY8cOOM130_provenance.
- NP891667.RAQmtk2BsP-YgKoR__CVQCtbQaYV9Em0_IYscS1gypOu8130_assertion description "[There was also a significant difference in the expression of IGLV3-21 between chronic lymphocytic leukemia and leukemic chronic lymphoproliferative disorders (29.4 vs 4.8%, P = 0.018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891667.RAQmtk2BsP-YgKoR__CVQCtbQaYV9Em0_IYscS1gypOu8130_provenance.
- assertion description "[There was also a significant difference in the expression of IGLV3-21 between chronic lymphocytic leukemia and leukemic chronic lymphoproliferative disorders (29.4 vs 4.8%, P = 0.018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP720759.RAeF3gUTdHv3jSUQWHw4mWR_I0LjkaWxnhgeRnthULuWM130_assertion description "[There was also a significant difference in the expression of IGLV3-21 between chronic lymphocytic leukemia and leukemic chronic lymphoproliferative disorders (29.4 vs 4.8%, P = 0.018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720759.RAeF3gUTdHv3jSUQWHw4mWR_I0LjkaWxnhgeRnthULuWM130_provenance.